Vitamin D and muscle strength is one of the few supplement questions where the research produced a genuinely uncomfortable answer. Modest doses helped. Larger doses did the opposite.
That pattern is unusual. Most of the time an ingredient either works or it doesn’t, and the debate is about how much benefit. Here the same nutrient, given in bigger amounts, made the outcome worse.
What this is actually measuring
Before the numbers, a note on what “muscle strength” means in this research.
The outcome that matters clinically isn’t grip strength on a dynamometer. It’s falls — and, downstream of falls, fractures. Over 90% of fractures result from falls[2], so the two travel together.
That’s why the trials in this area count how many people fell rather than measuring muscle directly. Strength, balance and reaction time all feed into that single number.
The trials that found benefit
Several trials using ordinary daily doses reported meaningful reductions.
- 800 IU daily with calcium cut falls by 27% over 12 months in European older adults, with benefit persisting for eight months after the supplements stopped[4]
- 700 IU daily reduced falls by 46% in women, though not significantly in men[4]
A review of this field concluded that benefit appears in institutionalised older adults with severe deficiency, at doses of at least 800 IU daily taken with calcium[3].
Note what those doses have in common. They’re modest, they’re daily, and the benefit showed up in people who were deficient to begin with.
The trials that found harm
Now the other direction.
An Australian trial gave 2,256 community-dwelling women aged 70 and over a single annual dose of 500,000 IU, or placebo[1]. The result was not neutral. Falls rose 15% and fractures rose 26%[1]. The excess risk was concentrated in the three months immediately following each annual dose.
A separate trial compared monthly regimens — 24,000 IU, 60,000 IU, and a combination — over one year. The two higher-dose groups had significantly more fallers than the 24,000 IU group[2]. Injurious falls were two to two-and-a-half times more common on the higher dose[2].
The same analysis found something worth pausing on. The risk of a first fall tended to be higher in participants who reached a blood level of 40 ng/mL or above than in those who stayed below 30[2].
Higher blood levels, in other words, were not simply better.
The U-shape
Put the two halves together and a curve appears rather than a line.
An observational study following 1,662 men aged 70 to 92 found a U-shaped relationship between vitamin D level and fracture risk[2]. The lowest fracture risk sat in a band around 24 to 28.8 ng/mL[2]. The comparable window for falls was roughly 20 to 40 ng/mL[2].
| Regimen | Reported outcome |
| 700–800 IU daily (with calcium) | Falls reduced 27–46% |
| 24,000 IU monthly | Reference group — fewest fallers |
| 60,000 IU monthly | Significantly more fallers |
| 500,000 IU annually | Falls +15%, fractures +26% |
[Table 1] Dose and outcome in falls research · Source: Summary of related exams and literature[1][2][3]
A review summarising this literature put the harmful range at 60,000–100,000 IU per month, or above 4,000 IU per day, with respect to falls, fracture risk and bone density[3].
A bit more detail — for readers who want the proposed mechanism. Large bolus doses appear to trigger a counter-regulatory hormonal response, with FGF-23 as the leading suspect[2]. FGF-23 drives phosphate excretion, and low phosphate causes muscle weakness by reducing ATP synthesis[2]. FGF-23 levels also correlate with frailty, itself a strong risk factor for falling[2]. This remains a hypothesis rather than an established mechanism.
What guidelines took from this
The practical guidance that emerged is narrower than what the supplement aisle suggests.
Commentary accompanying the monthly-dosing trial made a pointed argument[2]. The “aim for 30 ng/mL” strategy is not yet supported by randomised trials. Until it is, the prudent course is the Institute of Medicine position: people aged 70 and over should get 800 IU daily, without routine measurement of blood levels[2].
That’s a striking recommendation for two reasons. It sets a modest target, and it explicitly discourages routine testing — the opposite of the “test, then correct to an optimal level” approach that circulates widely.
Not every body agrees on thresholds, and this remains contested. But the direction of travel across the falls literature has been toward lower doses, taken daily, rather than large amounts spaced out.
If you’re in Korea
Two practical notes for readers here.
Vitamin D isn’t part of the standard national screening panel. The general health screening covers glucose, hemoglobin, liver enzymes and kidney function, but blood vitamin D is not among them. If you want the number, it’s a separate request.
High-dose formats are widely available, including monthly and injectable regimens. Given what the falls research found about bolus dosing, the regimen is worth discussing rather than defaulting to whatever is most convenient.
Korea also has a well-documented deficiency problem, which cuts the other way — the trials that found benefit were in deficient populations. That argues for finding out where you stand, not for assuming more is safer. Nutrient-specific reference material, including upper intake levels, is published by the NIH Office of Dietary Supplements[5].
Closing
What I had wrong was the shape of the relationship. I assumed vitamin D and muscle function ran in a straight line — too little is bad, more is better, and beyond some point extra simply does nothing.
The falls data doesn’t look like that. It looks like a curve with a floor in the middle, and both ends carry risk. A single annual dose large enough to sound impressive raised fractures by a quarter.
None of this argues against vitamin D. It argues against the specific idea that pushing blood levels higher is a strategy. The trials that helped used ordinary amounts, taken daily, in people who were short to begin with.
At a Glance
- The outcome measured in this research is falls, since over 90% of fractures result from falls
- 700–800 IU daily with calcium reduced falls by 27–46% in trials, mainly in deficient populations
- 60,000 IU monthly produced significantly more fallers than 24,000 IU monthly
- 500,000 IU annually raised falls 15% and fractures 26%, concentrated in the months after dosing
- Fracture risk follows a U-shape, with the lowest risk around 24–28.8 ng/mL
- Reaching 40 ng/mL or above was associated with a higher tendency to first fall than staying below 30
- One guideline position: 800 IU daily for people 70+, without routine blood testing
※ This article is for general information and does not replace medical advice, diagnosis or treatment. Dosing decisions depend on your individual vitamin D status, medication and health conditions. Do not start, stop or change a high-dose regimen on your own — discuss it with a clinician, particularly if you have a history of falls, fractures, kidney disease or hypercalcemia.
References
- Sanders KM et al., “Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial”, JAMA 2010;303(18):1815-1822, https://pubmed.ncbi.nlm.nih.gov/20460620/
- “Impact of Vitamin D and Calcium on Falls and Fractures in Older Adults”, Endocrine Practice, https://www.endocrinepractice.org/article/S1530-891X(25)00965-6/fulltext
- “Vitamin D supplementation and fracture risk: Evidence for a U-shaped effect”, Maturitas, https://www.maturitas.org/article/S0378-5122(20)30305-4/abstract
- STURDY trial protocol (summary of prior falls trials including Pfeifer and Bischoff-Ferrari), ClinicalTrials.gov, https://cdn.clinicaltrials.gov/large-docs/33/NCT02166333/Prot_000.pdf
- NIH Office of Dietary Supplements, “Dietary Supplement Fact Sheets”, https://ods.od.nih.gov/factsheets/list-all/